Related Experiment Video
Updated: Nov 8, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MiRNA-488-3p inhibits malignant progression of NSCLC by modulating ADAM9
1Department of Thoracic Surgery, Shanghai Key Laboratory of Clinical Geriatric Medicine, Huadong Hospital, Shanghai, China.
Abstract:
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "MiRNA-488-3p inhibits malignant progression of NSCLC by modulating ADAM9, by Y. Wu, Y. Wu, X.-Y. Chen, Y.-X. Niu, F.-Z. Lv, W. Gao, published in Eur Rev Med Pharmacol Sci 2020; 24 (17): 8893-8901-DOI: 10.26355/eurrev_202009_22830-PMID: 32964979" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/22830.
Insights
This article on MiRNA-488-3p and non-small cell lung cancer (NSCLC) has been withdrawn due to suspected research misconduct. The publisher retracted the study after authors failed to provide data originality proof.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality.
- MicroRNAs (miRNAs) play crucial roles in cancer development and progression.
- ADAM9 has been implicated in various cancers, including NSCLC.
Purpose of the Study:
- To investigate the role of microRNA-488-3p (miRNA-488-3p) in the malignant progression of NSCLC.
- To explore the potential regulatory relationship between miRNA-488-3p and ADAM9 in NSCLC.
Main Methods:
- The study aimed to analyze the expression levels of miRNA-488-3p and ADAM9 in NSCLC tissues and cell lines.
- Functional experiments were proposed to assess the impact of miRNA-488-3p on NSCLC cell proliferation, migration, and invasion.
- Mechanistic studies were intended to elucidate how miRNA-488-3p modulates ADAM9 expression.
Main Results:
- The original study reported that miRNA-488-3p inhibited NSCLC progression.
- It was suggested that miRNA-488-3p exerted its effects by downregulating ADAM9 expression.
- The findings indicated a potential tumor-suppressive role for miRNA-488-3p in NSCLC.
Conclusions:
- The original study concluded that miRNA-488-3p acts as a tumor suppressor in NSCLC by targeting ADAM9.
- This miRNA was proposed as a potential therapeutic target for NSCLC treatment.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation

